Cargando…

Chinese Medicine for Chronic Obstructive Pulmonary Disease: A Pilot Study on Patient Preferences

PURPOSE: The patient’s preference plays an important role in clinical practice. There currently is no available evidence regarding the perception and attitudes of patients with chronic obstructive pulmonary disease (COPD) towards the use of Chinese medicine (CM) approaches. This study was designed t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Shaonan, Lai, Jiaqi, Wu, Lei, Guo, Xinfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275201/ https://www.ncbi.nlm.nih.gov/pubmed/34267508 http://dx.doi.org/10.2147/PPA.S316872

Ejemplares similares

Safety of Chinese Herbal Medicine for Chronic Obstructive Pulmonary Disease
por: Coyle, Meaghan, et al.
Publicado: (2015)

Comparative effectiveness of six Chinese herb formulas for acute exacerbation of chronic obstructive pulmonary disease: a systematic review and network meta-analysis
por: Liu, Shaonan, et al.
Publicado: (2019)

Comparative effectiveness of six Chinese herb formulas for acute exacerbation of chronic obstructive pulmonary disease: protocol for systematic review and network meta-analysis
por: Liu, Shaonan, et al.
Publicado: (2017)

Chinese Herbal Medicine (Weijing Decoction) Combined with Pharmacotherapy for the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
por: Liu, Shaonan, et al.
Publicado: (2014)

Comparative Effectiveness and Safety of Seven Qi-Tonifying Chinese Medicine Injections for AECOPD Patients: A Systematic Review and Network Meta-Analysis
por: Deng, Xueyi, et al.
Publicado: (2021)

Protocol of the Development of a Core Outcome Set for Ischemic Stroke in Clinical Trials of Chinese Medicine
por: Xie, Qianwen, et al.
Publicado: (2020)

Panax ginseng therapy for chronic obstructive pulmonary disease: a clinical trial protocol and pilot study
por: Wu, Lei, et al.
Publicado: (2014)

Editorial: Advances in integrative medicine for neurodegenerative diseases: from basic research to clinical practice
por: Liu, Shaonan, et al.
Publicado: (2023)

Effect and safety of roflumilast for chronic obstructive pulmonary disease in Chinese patients
por: Liu, Dong-yang, et al.
Publicado: (2018)

Chinese herbal medicine for patients with vascular cognitive impairment no dementia: protocol for a systematic review
por: Feng, Mei, et al.
Publicado: (2016)

Precision medicine in chronic obstructive pulmonary disease
por: Halpin, David M.G.
Publicado: (2022)

Are Patients with Asthma and Chronic Obstructive Pulmonary Disease Preferred Targets of COVID-19?
por: Bouazza, Belaid, et al.
Publicado: (2021)

Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease
por: Morrell, Nicholas W, et al.
Publicado: (2005)

A pilot crossover trial assessing the exercise performance patients with chronic obstructive pulmonary disease
por: Chao, Ke-Yun, et al.
Publicado: (2022)

Lead Screening for Chronic Obstructive Pulmonary Disease of IKK2 Inhibited by Traditional Chinese Medicine
por: Tsou, Yung-An, et al.
Publicado: (2014)

Add-On Effects of Chinese Herbal Medicine for Post-Stroke Spasticity: A Systematic Review and Meta-Analysis
por: Cai, Yiyi, et al.
Publicado: (2019)

Assessment of patients’ preferences regarding the characteristics associated with the treatment of chronic obstructive pulmonary disease
por: Bulcun, Emel, et al.
Publicado: (2014)

Combination of Chinese and Western Medicine Optimizes the Intestinal Microbiota of Exacerbated Chronic Obstructive Pulmonary Disease in Rats
por: Li, Xiaojun, et al.
Publicado: (2021)

Advances in Pharmacological Actions and Mechanisms of Flavonoids from Traditional Chinese Medicine in Treating Chronic Obstructive Pulmonary Disease
por: Yang, Yang, et al.
Publicado: (2020)

Oral Huangqi Formulae for Stable Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis
por: Wu, Lei, et al.
Publicado: (2013)

Healthcare Professionals’ Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease
por: Dankers, Marloes, et al.
Publicado: (2020)

Chinese Herbal Medicine and Salmeterol and Fluticasone Propionate for Chronic Obstructive Pulmonary Disease: Systematic Review and Network Meta-Analysis
por: Chung, Vincent C.H., et al.
Publicado: (2016)

Content validity of preference-based measures for economic evaluation in chronic obstructive pulmonary disease
por: Mehdipour, Ava, et al.
Publicado: (2021)

Aspergillus infection in chronic obstructive pulmonary diseases
por: Guo, Liang, et al.
Publicado: (2023)

Effects of Ipratropium Bromide Combined with Traditional Chinese Medicine Intervention on the Pulmonary Function and Psychological Status of Patients with Chronic Obstructive Pulmonary Disease
por: Ye, Wen-Yi, et al.
Publicado: (2023)

Expert consensus and operational guidelines on exercise rehabilitation of chronic obstructive pulmonary disease with integrating traditional Chinese medicine and Western medicine
por: Chen, Xuan, et al.
Publicado: (2021)

Pilot Study of Chronic Obstructive Pulmonary Disease in an Industrial Town in India
por: Sharma, Arun Kumar, et al.
Publicado: (2019)

Association of Chinese Herbal Medicines Use with Development of Chronic Obstructive Pulmonary Disease Among Patients with Rheumatoid Arthritis: A Population-Based Cohort Study
por: Lin, Miao-Chiu, et al.
Publicado: (2020)

Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat(®) Soft Mist(™) Inhaler
por: Hodder, Richard, et al.
Publicado: (2009)

Evaluation of Patient Preference and Willingness to Pay for Attributes of Maintenance Medication for Chronic Obstructive Pulmonary Disease (COPD)
por: Kawata, Ariane K., et al.
Publicado: (2014)

Efficacy of budesonide/formoterol and tiotropium combination for the treatment of Chinese patients with chronic obstructive pulmonary disease
por: Feng, Jun-fei, et al.
Publicado: (2018)

Chinese herbal injections plus Western Medicine on inflammatory factors for patients with acute exacerbation of chronic obstructive pulmonary disease: a systematic review and network meta-analysis
por: Zhu, Xiuying, et al.
Publicado: (2023)

Pulmonary embolism with chronic obstructive pulmonary disease
por: Yang, Ruohan, et al.
Publicado: (2021)

Evaluation of the Vibe Actigraph in Patients With Chronic Obstructive Pulmonary Disease: A Pilot Study
Publicado: (2020)

The Effects of Traditional Chinese Exercise in Patients with Chronic Obstructive Pulmonary Disease: A Meta-Analysis
por: Luo, Xiaotian, et al.
Publicado: (2016)

Association of nsv823469 copy number loss with decreased risk of chronic obstructive pulmonary disease and pulmonary function in Chinese
por: Chen, Xiaoliang, et al.
Publicado: (2017)

Impact of obstructive sleep apnea on pulmonary hypertension in patients with chronic obstructive pulmonary disease
por: Sun, Wan-Lu, et al.
Publicado: (2019)

The effect of acupoint application of traditional Chinese medicine for the treatment of chronic obstructive pulmonary disease: A protocol for systematic review and meta-analysis
por: Liu, Yefang, et al.
Publicado: (2020)

Interleukin-33 gene polymorphisms and chronic obstructive pulmonary disease in the Chinese Han population
por: Xu, Xia, et al.
Publicado: (2020)

Maintenance inhaler therapy preferences of patients with asthma or chronic obstructive pulmonary disease: a discrete choice experiment
por: Tervonen, Tommi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s8ejtn4fk8qnb9jeo4c28fmpuk